Eisai Research Institute Of Boston Inc Wilmington, MA - 01887

Eisai Research Institute Of Boston Inc is categorized under Commercial Medical Research in Wilmington, MA .

Eisai Research Institute Of Boston Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Soichi Matsuno at the company’s branch by writing to 100 Research Drive, Wilmington, Massachusetts MA 01887 or by phoning (978) 794-1117. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Eisai Research Institute Of Boston Inc
Contact Person: Soichi Matsuno
Address: 100 Research Drive, Wilmington, Massachusetts 01887
Phone Number: (978) 794-1117
Website Address: eisai.com
Annual Revenue (USD): Unknown
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Eisai Research Institute Of Boston Inc was started in 0 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Soichi Matsuno for inquiries that concern Eisai Research Institute Of Boston Inc by calling the company number (978) 794-1117, as your correspondence is most welcome. Additionally, the physical location of the branch of Eisai Research Institute Of Boston Inc can be found at the coordinates 42.60264,-71.160473 as well as the street address 100 Research Drive in Wilmington, Massachusetts 01887.

For its online presence, you may visit Eisai Research Institute Of Boston Inc’s website at eisai.com and engage with its social media outlets through on Twitter and on Facebook.